Skip to main content
Trending storyContinuously updated

Siloton wins €9.98M Innovate UK contract for handheld eye imaging

1 reports1 report sources4 hours agoUpdate

Get up to speed on this story

AI Summary

Bristol-based MedTech startup Siloton won a €9.98M (£8.4M) Innovate UK contract to speed development of its handheld GiraffeOCT eye imaging system. The two-year contract covers design of in-clinic and at-home versions and trials of both, including clinical trials with Sunderland Specialist Eye Hospital for the in-clinic device, giving patients in the North East and North Cumbria access during development. Siloton expects the project to cut development by up to two years and grow its team to 16 by August 2028. It also plans to raise further investment to support its second-generation CheetahOCT device, which is designed to measure different retinal layers and detect more conditions.

AI-generated from reports · 3 hours agoUpdate

Latest updatesOct 19 17:12
Bristol's Siloton wins €9.98M Innovate UK contract for handheld eye imaging

Report timeline

Follow the reports to understand different sides of the story.

Oct 19
  1. EU-StartupsTop Deals
    Bristol's Siloton wins €9.98M Innovate UK contract for handheld eye imaging

    Siloton, a Bristol-based MedTech startup, won a €9.98M (£8.4M) Innovate UK contract to accelerate its handheld GiraffeOCT eye imaging system. The two-year contract covers in-clinic and at-home versions plus trials with Sunderland Specialist Eye Hospital, and Siloton expects it could cut development by up to two years. The company plans to raise further investment for its second-generation CheetahOCT device.

Trend for this story

Comparable range current
9
Comparable range peak
10Oct 19 18:00
Change in the last 24 hours
–

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing